Skip to main content
. 2017 Feb 14;13(4):2397–2402. doi: 10.3892/ol.2017.5742

Figure 2.

Figure 2.

Treatment with ZER decreases human CHL-1 melanoma cell viability and proliferation. Melanoma cell lines were treated with 0, 1, 2, 4, 8 and 16 µg/ml ZER, prior to the determination of (A) cell viability and (B) proliferation, relative to the Cont cells. Values are presented as the mean ± standard error of the mean (n=8). *P<0.05 vs. Cont. ZER, zerumbone; Cont, control.